Clinical Trial Update: Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating molecular signatures associated with response to inhaled corticosteroids in chronic obstructive pulmonary disease, with anal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Maria Joyera Rodríguez | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: RECRUITING